Adia Med ADIA
OTC ADIA
$0.13 +0.01 (+8.33%)
At close: Nov 10, 2026 · 4:00 PM EST

Adia Med (ADIA) Current Deferred Revenue (2025 - 2026)

Updated

Adia Nutrition's Current Deferred Revenue came in at $218,000 for Q1 2026.

Analysis

Adia Med (ADIA) Current Deferred Revenue (2025 - 2026) Analysis & Trends

At the end of FY2025, Adia Nutrition's Current Deferred Revenue was $14,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Adia Med 12.27 Mn 11.92 Mn 282,580.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 64,000.00
Mar 31, 2026 218,000.00
Dec 31, 2025 14,000.00
API Access

Adia Med Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ADIA&period=max&api_key=YOUR_API_KEY